Actively Recruiting
Study of Immune Response and Heart Healing After a Heart Attack Using Advanced Imaging
Led by Wuerzburg University Hospital · Updated on 2023-05-25
57
Participants Needed
2
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how the adaptive immune system responds after an acute myocardial infarction heart attack and how this response affects heart healing and remodeling. The study focuses on lymphocytes as a potential target for treatment and aims to find blood-based markers that predict immune response to heart injury. The study also explores if imaging of lymph nodes can provide useful information about this immune response and predict heart function decline over time. Participants will undergo a multimodal imaging approach that includes CXCR4-targeted PETCT scans during the hospital stay, as well as serial cardiac magnetic resonance CMR and echocardiography Echo scans. These imaging tests will measure the size of mediastinal lymph nodes and the CXCR4 PET signal in lymph nodes, heart muscle, spleen, and bone marrow. The study will also collect blood samples for immune cell analysis. During the study, participants will be closely monitored with these imaging tests and blood collections over a 12-month period. Researchers will assess how CXCR4 PET signals relate to the immune response and heart damage, and how they predict changes in heart function during follow-up. The main outcome measure is CXCR4 PET uptake after myocardial infarction. Secondary measures include correlations between imaging signals, lymphocytes in blood, heart damage, and clinical course over one year.
CONDITIONS
Brief Title
Lymphatic Organs and Myocardium After Myocardial Infarction
Research Team
T
Theresa Reiter, MD
R
Rudolf Werner, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here